May 3, 2024 7:30 am EDT Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Apr 1, 2024 8:30 am EDT Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 18, 2024 7:30 am EDT Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
Mar 5, 2024 7:30 am EST Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 1, 2024 4:05 pm EST Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 1, 2024 7:30 am EST Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
Dec 15, 2023 7:30 am EST Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 27, 2023 7:30 am EST Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
